Trial Profile
A prospective, observational, multi-center, cohort study evaluating the patterns of treatment modality and survival outcomes in hepatocellular carcinoma patients with portal vein invasion in Korea
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Dec 2018
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 07 Dec 2018 New trial record
- 13 Nov 2018 Results presented at The Liver Meeting 2018: 69th Annual Meeting of the American Association for the Study of Liver Diseases